151 related articles for article (PubMed ID: 28584719)
1. SIX4 promotes metastasis via activation of the PI3K-AKT pathway in colorectal cancer.
Li G; Hu F; Luo X; Hu J; Feng Y
PeerJ; 2017; 5():e3394. PubMed ID: 28584719
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of the potential role and prognostic value of sine oculis homeobox homolog family in colorectal cancer.
Fang ZX; Li CL; Wu Z; Hou YY; Wu HT; Liu J
World J Gastrointest Oncol; 2022 Nov; 14(11):2138-2156. PubMed ID: 36438701
[TBL] [Abstract][Full Text] [Related]
3. SIX4 promotes metastasis through STAT3 activation in breast cancer.
Sun X; Ma J; Chen Q; Hou Z; Luo X; Wang G; Wang J; Hu J; Cao Z
Am J Cancer Res; 2020; 10(1):224-236. PubMed ID: 32064163
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of SIX4 inhibits pancreatic cancer cells via apoptosis induction.
Heiat M; Rezaei E; Gharechahi J; Abbasi M; Behroozi J; Abyazi MA; Baradaran B
Med Oncol; 2023 Sep; 40(10):287. PubMed ID: 37656231
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Nicotinamide N-methyltransferase mainly covers stroma of colorectal cancer and correlates with unfavorable survival by its product 1-MNA.
Yang J; Tong Q; Zhang Y; Yuan S; Gao Y; Deng K; Wang Y; Lu J; Xie X; Zhang Z; Zhang J
J Cancer; 2021; 12(20):6170-6181. PubMed ID: 34539890
[No Abstract] [Full Text] [Related]
6. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
[TBL] [Abstract][Full Text] [Related]
7. miR-802 inhibits the proliferation, invasion, and epithelial-mesenchymal transition of glioblastoma multiforme cells by directly targeting SIX4.
Huang W; Shi Y; Han B; Wang Q; Zhang B; Qi C; Liu F
Cell Biochem Funct; 2020 Jan; 38(1):66-76. PubMed ID: 31702057
[TBL] [Abstract][Full Text] [Related]
8. Overexpressed ACP5 has prognostic value in colorectal cancer and promotes cell proliferation and tumorigenesis via FAK/PI3K/AKT signaling pathway.
Bian ZQ; Luo Y; Guo F; Huang YZ; Zhong M; Cao H
Am J Cancer Res; 2019; 9(1):22-35. PubMed ID: 30755809
[TBL] [Abstract][Full Text] [Related]
9. Interferon-induced transmembrane protein 2 is a prognostic marker in colorectal cancer and promotes its progression by activating the PI3K/AKT pathway.
Liu Y; Liang J; Li X; Huang J; Huang J; Wang J
Discov Oncol; 2024 May; 15(1):191. PubMed ID: 38802621
[TBL] [Abstract][Full Text] [Related]
10. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
[No Abstract] [Full Text] [Related]
11. PABPC1L depletion inhibits proliferation and migration via blockage of AKT pathway in human colorectal cancer cells.
Wu YQ; Ju CL; Wang BJ; Wang RG
Oncol Lett; 2019 Mar; 17(3):3439-3445. PubMed ID: 30867782
[TBL] [Abstract][Full Text] [Related]
12. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
[TBL] [Abstract][Full Text] [Related]
13. NCOA5 promotes proliferation, migration and invasion of colorectal cancer cells via activation of PI3K/AKT pathway.
Sun K; Wang S; He J; Xie Y; He Y; Wang Z; Qin L
Oncotarget; 2017 Dec; 8(64):107932-107946. PubMed ID: 29296214
[TBL] [Abstract][Full Text] [Related]
14. SIX4 acts as a master regulator of oncogenes that promotes tumorigenesis in non-small-cell lung cancer cells.
Tang X; Yang Y; Song X; Liu X; Wang X; Huang F; Li Y; Chen F; Wan H
Biochem Biophys Res Commun; 2019 Aug; 516(3):851-857. PubMed ID: 31266633
[TBL] [Abstract][Full Text] [Related]
15. Long Non-Coding RNA SH3PXD2A-AS1 Promotes Cell Progression Partly Through Epigenetic Silencing P57 and KLF2 in Colorectal Cancer.
Ma Z; Peng P; Zhou J; Hui B; Ji H; Wang J; Wang K
Cell Physiol Biochem; 2018; 46(6):2197-2214. PubMed ID: 29734178
[TBL] [Abstract][Full Text] [Related]
16. SIX4 upregulates IDH1 and metabolic reprogramming to promote osteosarcoma progression.
Li B; Dang X; Duan J; Zhang G; Zhang J; Song Q
J Cell Mol Med; 2023 Jan; 27(2):259-265. PubMed ID: 36601689
[TBL] [Abstract][Full Text] [Related]
17. Potential role of LINC00996 in colorectal cancer: a study based on data mining and bioinformatics.
Ge H; Yan Y; Wu D; Huang Y; Tian F
Onco Targets Ther; 2018; 11():4845-4855. PubMed ID: 30147336
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of CHKA contributes to tumor progression and metastasis and predicts poor prognosis in colorectal carcinoma.
Hu L; Wang RY; Cai J; Feng D; Yang GZ; Xu QG; Zhai YX; Zhang Y; Zhou WP; Cai QP
Oncotarget; 2016 Oct; 7(41):66660-66678. PubMed ID: 27556502
[TBL] [Abstract][Full Text] [Related]
19. High expression of DJ-1 promotes growth and invasion via the PTEN-AKT pathway and predicts a poor prognosis in colorectal cancer.
Lin Y; Chen Q; Liu QX; Zhou D; Lu X; Deng XF; Yang H; Zheng H; Qiu Y
Cancer Med; 2018 Mar; 7(3):809-819. PubMed ID: 29441725
[TBL] [Abstract][Full Text] [Related]
20. Identification of Genes Related to Clinicopathological Characteristics and Prognosis of Patients with Colorectal Cancer.
Gao X; Yang J
DNA Cell Biol; 2020 Apr; 39(4):690-699. PubMed ID: 32027181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
